ORIGINAL RESEARCH article

Front. Pediatr., 29 October 2021

Sec. Pediatric Pulmonology

Volume 9 - 2021 | https://doi.org/10.3389/fped.2021.751386

Factors Associated With the Presence of Tuberculous Empyema in Children With Pleural Tuberculosis

  • 1. Department of Lab Medicine, Shandong Provincial Chest Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China

  • 2. Department of Lab Medicine, Shandong Public Health Clinical Center, Shandong University, Jinan, China

  • 3. Department of Lab Medicine, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China

  • 4. Shandong Key Laboratory of Infectious Respiratory Disease, Jinan, China

Article metrics

View details

5

Citations

2,5k

Views

915

Downloads

Abstract

Background: Until now, the factor of tuberculous empyema (TE) in children with pleural tuberculosis (TB) remains unclear. Therefore, a retrospective study was conducted to assess the factors associated with the presence of TE in children.

Methods: Between January 2006 and December 2019, consecutive children patients (≤ 15 years old) with suspected pleural TB were selected for further analysis. Empyema was defined as grossly purulent pleural fluid. The demographic, clinical, laboratory, and radiographic features were collected from the electrical medical records retrospectively. Univariate and multivariate logistic regressions were used to explore the factors associated with the presence of TE in children with pleural TB.

Results: A total of 154 children with pleural TB (definite, 123 cases; possible, 31 cases) were included in our study and then were classified as TE (n = 27) and Non-TE (n = 127) groups. Multivariate analysis revealed that surgical treatment (age- and sex-adjusted OR = 92.0, 95% CI: 11.7, 721.3), cavity (age- and sex-adjusted OR = 39.2, 95% CI: 3.2, 476.3), pleural LDH (>941 U/L, age- and sex-adjusted OR = 14.8, 95% CI: 2.4, 90.4), and temperature (>37.2°C, age- and sex-adjusted OR = 0.08, 95% CI: 0.01, 0.53) were associated with the presence of TE in children with pleural TB.

Conclusion: Early detection of the presence of TE in children remains a challenge and several characteristics, such as surgical treatment, lung cavitation, high pleural LDH level, and low temperature, were identified as factors of the presence of TE in children with pleural TB. These findings may improve the management of childhood TE.

Introduction

According to World Health Organization (WHO) report, in 2018, the global tuberculosis (TB) burden was estimated to be 10.0 million and 1.2 million deaths occurred due to TB (1). Children constitute a significant proportion and account for 11% of total TB cases (1). In addition, at least 200,000 children died from TB in 2018 worldwide. In China, although the incidence of TB in children decreases from 29 per 100,000 in 2008 to 19 per 100,000 in 2017, TB remained the most common bacterial infection in children (2). Due to the considerable TB burden in children, effective measures are important to improve the TB control in children and initiate the diagnosis and treatment of childhood TB at an earlier stage.

Currently, tuberculous empyema (TE) remains a serious threat in China. Our previous study demonstrated that in adults, empyema was reported in 8.9% of patients with pleural TB and significant associations between several clinical characteristics (such as sex, pleural adenosine deaminase (ADA), white blood cell (WBC), and pulmonary TB) and presence of TE were observed (3). In the past decades, the treatment and outcome of empyema in children have been well characterized in several studies. In general, treatments, such as surgical operation or drugs, remain dependent on the empyema stage. For example, the conservative approach remains effective in the management of empyema in children (4); likewise, in adults, surgical management for stage III pediatric empyema is safe, effective, and well tolerated by children (5–7). However, compared with childhood pleural TB without empyema, children TE remains a serious challenge due to the severity, cost, and outcome.

Unfortunately, due to the lack of evidence, the factor of TE in children with pleural TB remains unclear. Therefore, in this retrospective study, we aimed to assess the factors associated with the presence of tuberculous empyema in children with pleural TB. It enables health providers to identify the characteristics of TE in children and develop appropriate strategies to improve the management of childhood TE. Moreover, it would be useful to identify TE from children with pleural TB at a high risk, and then appropriate treatment may be provided timely.

Materials and Methods

Between January 2006 and December 2019, consecutive children patients (≤ 15 years old) with suspected pleural TB were selected for further analysis. Empyema was defined as grossly purulent pleural fluid (8). Definite pleural TB was defined as positive mycobacterial culture (sputum, pleural effusion, or pleural tissue) or suggested by pathological evidences (such as caseous necrosis, or Langhans' giant cells). Possible pleural TB was diagnosed based on the combinations of clinical symptoms and TB assays (such as TB RT-PCR and acid-fast bacilli (AFB) smear). The demographic (such as age, sex, and weight), clinical (such as symptoms, vital signs, and underling disease), laboratory (such as blood count and chemistry), and radiographic features were collected from the electrical medical records retrospectively.

Statistical analysis was performed using SPSS version 16.0 (SPSS, Chicago, IL, USA). All data were presented as mean ± standard deviation (SD). Univariate logistic regression analysis was performed to assess factors for the presence of TE, and variables with P-value <0.1 were included for multivariate logistic regression analysis. Multivariate logistic regression analysis was then performed and the corresponding odds ratios (OR) and 95% confidence interval (CI), adjusted by age and sex, were calculated (9). In addition, to allow a better clinical understanding, continuous variables were transformed into categorical variables according to receiver operating characteristic curve (ROC) analysis. The accuracy of the multivariate model was evaluated using the Hosmer-Lemeshow goodness-of-fit test. The associations between the parameters were estimated using the Spearman correlation test. All tests were 2-sided, and a P-value < 0.05 was considered significant.

Results

Patient Characteristics

The demographic data, clinical characteristics, laboratory, and radiographic findings collected from enrolled patients were shown in Tables 1, 2. A total of 154 children with pleural TB (definite, 123 cases; possible, 31 cases) were included in our study and then were classified as TE (n = 27) and Non-TE (n = 127) groups. The patients have a mean age of 12.4 ± 3.3 years, and boys accounted for 64.9% (100 patients). One hundred and three were tested for HIV status, and all were HIV-negative. The weight was measured with a mean of 46.1 ± 16.2 kg. Among the 154 children patients, 93 (60.4%) were from rural areas. The vital signs were as follows: temperature, 37.2 ± 0.9°C; heart rate, 97.6 ± 16.0 beats/min; respiratory rate, 22.5 ± 2.7 breaths/min; blood pressure, 111.4 ± 12.3/69.2 ± 8.5 mmHg.

Table 1

Total (n)TE (n)Non-TE (n)P-valueOR (95% CI)
N15427127
Vital signs
Temperature (°C)37.2 ± 0.936.8 ± 0.737.3 ± 0.90.0060.420 (0.225, 0.781)
Heart rate97.6 ± 16.094.8 ± 16.497.3 ± 16.00.310
Respiratory rate22.5 ± 2.722.1 ± 2.522.5 ± 2.90.325
Systolic pressure111.4 ± 12.3114.2 ± 10.0111.0 ± 11.80.191
Diastolic pressure69.2 ± 8.570.8 ± 9.168.1 ± 7.70.275
Medical history
Contact history of TB20 (13.0%)1 (3.7%)19 (15.0%)0.147
Transferred times2.1 ± 1.02.0 ± 1.02.2 ± 1.10.788
Transferred from a teaching hospital91 (59.1%)16 (59.3%)75 (59.1%)0.984
Times of hospitalization2.0 ± 1.62.9 ± 2.51.7 ± 1.30.0021.431 (1.141, 1.793)
Treatment delay (days)61.8 ± 134.660.7 ± 67.691.8 ± 177.80.965
Surgical treatment29 (18.8%)19 (70.4%)10 (7.9%)0.00027.787 (9.739, 79.288)
Symptoms and complications
Cough84 (54.5%)13 (48.1%)71 (55.9%)0.463
Fever (>38°C)134 (87.0%)20 (74.1%)114 (89.8%)0.0340.326 (0.116, 0.917)
Chest pain69 (44.8%)13 (48.1%)56 (44.1%)0.701
Dyspnea42 (27.3%)6 (22.2%)36 (28.3%)0.518
Sputum production29 (18.8%)5 (18.5%)24 (18.9%)0.964
Cavity7 (4.5%)3 (11.1%)4 (3.1%)0.091
Loculated effusion27 (17.5%)10 (37.0%)17 (13.4%)0.0053.806 (1.497, 9.679)
Clinical chemistry (pleural effusion)
Total Protein48.5 ± 7.245.9 ± 8.049.4 ± 7.30.215
Total Bilirubin (mmol/L)8.6 ± 5.611.5 ± 10.18.2 ± 5.00.109
Adenosine deaminase (U/L)60.3 ± 28.871.5 ± 49.461.6 ± 28.40.198
Glucose (mmol/L)3.3 ± 1.52.3 ± 1.73.4 ± 1.70.0290.606 (0.386, 0.951)
Lactate dehydrogenase (U/L)876.7 ± 642.81505.4 ± 1308.1842.1 ± 491.90.0101.001 (1.000, 1.002)
Amylase (U/L)29.6 ± 10.425.7 ± 11.032.0 ± 11.60.210
Other analysis
Erythrocyte sedimentation rate (mm/h)40.8 ± 26.429.6 ± 26.042.4 ± 27.60.0210.977 (0.958, 0.996)

Univariate analysis of the demographic data associated with TE in childhood pleural TB.

TB, tuberculosis; OR, odds ratio; CI, confidence interval.

Table 2

Total (n)TE (n)Non-TE (n)P-value
N15427127
Demographic characteristics
Age (years)12.4 ± 3.312.9 ± 3.012.3 ± 3.40.366
Sex (male)100 (64.9%)17 (63.0%)83 (65.4%)0.813
Weight (Kg)46.1 ± 16.246.5 ± 17.044.9 ± 14.90.889
Rural area93 (60.4%)17 (63.0%)76 (59.8%)0.763
Effusion sites
Left62 (40.3%)10 (37.0%)52 (40.9%)0.707
Right74 (48.1%)13 (48.1%)61 (48.0%)0.991
Both18 (11.7%)4 (14.8%)14 (11.0%)0.579
Comorbidity
Pulmonary TB89 (57.8%)14 (51.9%)75 (59.1%)0.492
Tuberculous lymphadenitis13 (8.4%)4 (14.8%)9 (7.1%)0.200
Milliary TB7 (4.5%)2 (7.4%)5 (3.9%)0.439
Tuberculous meningitis4 (2.6%)1 (3.7%)3 (2.4%)0.693
Bronchial tuberculosis3 (1.9%)03 (2.4%)0.999
Clinical Chemistry (serum)
Total protein (g/L)68.7 ± 6.968.2 ± 7.269.3 ± 7.50.673
Albumin (g/L)38.8 ± 4.838.7 ± 5.238.7 ± 4.90.908
Blood urea nitrogen (mmol/L)3.9 ± 1.23.6 ± 1.04.0 ± 1.20.174
Creatinine (μmmol/L)52.3 ± 15.355.7 ± 14.749.2 ± 13.90.227
Glucose (mmol/L)4.8 ± 1.24.8 ± 0.64.9 ± 1.60.908
Lactate dehydrogenase (U/L)219.8 ± 71.1220.6 ± 82.2208.8 ± 54.00.951
Blood analysis
White blood cell (109/L)7.3 ± 2.66.8 ± 2.07.4 ± 2.80.320
Red blood cell (1012/L)4.4 ± 0.54.6 ± 0.54.5 ± 0.50.114
Hemoglobin (g/L)121.2 ± 14.2124.2 ± 18.4120.4 ± 14.00.238
Hematocrit36.6 ± 3.937.3 ± 4.636.6 ± 4.00.299
Mean corpuscular volume (fL)82.4 ± 5.181.5 ± 5.582.3 ± 5.00.304
Mean corpuscular hemoglobin (pg)27.3 ± 2.127.1 ± 2.627.1 ± 1.80.579
Mean corpuscular hemoglobin concentration (g/L)331.3 ± 12.7332.2 ± 13.3329.1 ± 10.30.707
Platelet (109/L)352.8 ± 129.0333.2 ± 122.8359.5 ± 146.90.393
Neutrophil (109/L)5.1 ± 6.24.2 ± 1.54.7 ± 2.30.263
Lymphocyte (109/L)1.7 ± 0.91.8 ± 0.71.7 ± 0.80.832
Monocyte (109/L)0.8 ± 0.40.7 ± 0.30.8 ± 0.40.307
Coefficient of variation of red cell distribution width (%)13.9 ± 1.814.4 ± 2.114.1 ± 2.00.129
Flow cytometry
CD19+ (%)24.8 ± 20.119.4 ± 9.525.8 ± 19.70.432
CD3+ (%)62.4 ± 13.764.4 ± 12.161.5 ± 13.50.658
CD3+CD4+ (%)33.1 ± 9.135.8 ± 7.834.1 ± 9.50.379
CD3+CD8+ (%)24.0 ± 12.024.5 ± 10.422.4 ± 10.70.902
CD3-CD16+CD56+ (%)11.8 ± 6.210.9 ± 5.711.6 ± 6.90.657
CD4+/CD8+ (%)2.8 ± 3.91.9 ± 1.42.8 ± 3.70.531

Univariate analysis of the demographic data associated with TE in childhood pleural TB.

TB, tuberculosis.

Twenty (13.0%) patients had a TB contact history, and surgical techniques were employed in the 29 (18.8%) patients. Prior to the admission to our center, most of them (91, 59.1%) were treated at a teaching hospital, and the mean times of hospitalization were 2.0 ± 1.6. The most common symptom was fever (134, 87.0%), followed by cough (84, 54.5%), chest pain (69, 44.8%), dyspnea (42, 27.3%), and sputum production (29, 18.8%). Cavity and loculated effusion revealed by radiographic examinations were observed in 7 (4.5%, 7/154) and 27 (17.5%, 27/154) patients, respectively. In addition, 62 (40.3%, 62/154) patients had effusion on the left side, 74 (48.1%, 74/154) on the right side, and 18 (11.7%, 18/154) on the both-side. Out of the total of 154 study patients, 89 (57.8%) had pulmonary TB, 13 (8.4%) had tuberculous lymphadenitis, 7 (4.5%) had milliary TB, 4 (2.6%) had tuberculous meningitis, 3 (1.9%) had bronchial TB, and the remaining 38 (24.7%) were isolated pleural TB.

Other characteristics, such as clinical chemistry analysis (serum or pleural effusion), blood cell analysis, and flow cytometry analysis, were summarized in Tables 1, 2.

Univariate and Multivariate Analysis

Table 1 shows the univariate analysis of risk factors, comparing patients with TE with patients without TE. It was found that the presence of empyema was associated with temperature (OR = 0.420, 95% CI: 0.225, 0.781), hospitalization times (OR = 1.431, 95% CI: 1.141, 1.793), surgical treatment (OR = 27.787, 95% CI: 9.739, 79.288), fever (OR = 0.326, 95% CI: 0.116, 0.917), loculated effusion (OR = 3.806, 95% CI: 1.497, 9.679), pleural glucose (OR = 0.606, 95% CI: 0.386, 0.951), pleural LDH (OR = 1.001, 95% CI: 1.000, 1.002), and erythrocyte sedimentation rate (ESR, OR = 0.977, 95% CI: 0.958, 0.996) (all P < 0.05).

To make the results as readily understandable as possible, continuous variables were converted into dichotomous categorical variables based on the cut-off points determined with ROC analysis, and the corresponding optimal cut-off values were 37.2°C, 29 mm/h, 2.98 mmol/L, and 941 U/L, for temperature, ESR, pleural glucose, and LDH, respectively. Further multivariate analysis (Hosmer–Lemeshow goodness-of-fit test: χ2 = 2.780, df = 8, P = 0.947) revealed that surgical treatment (age- and sex-adjusted OR = 92.0, 95% CI: 11.7, 721.3), cavity (age- and sex-adjusted OR = 39.2, 95% CI: 3.2, 476.3), pleural LDH (>941 U/L, age- and sex-adjusted OR = 14.8, 95% CI: 2.4, 90.4), and temperature (>37.2°C, age- and sex-adjusted OR = 0.08, 95% CI: 0.01, 0.53) were associated with the presence of TE in children with pleural TB (Table 3).

Table 3

Adjusted (age and sex) ORP-value
Surgical treatment92.0 (11.7, 721.3)<0.001
Cavity39.2 (3.2, 476.3)0.004
Pleural LDH (>941 U/L)14.8 (2.4, 90.4)0.004
Temperature (> 37.2°C)0.08 (0.01, 0.53)0.009

Age- and sex-adjusted OR for risk factors associated with TE in childhood pleural TB.

TB, tuberculosis; OR, odds ratio; CI, confidence interval.

Discussion

Until now, factors that affect the presence of empyema remain uncertain. In this study, the associations between TE and clinical characteristics were assessed in a referral TB hospital. Our study found that surgical treatment, cavity, pleural LDH, and temperature were associated with the presence of TE in children with pleural TB. To our knowledge, this is the first report investigating factors of the presence of TE among children with pleural TB. Our findings may improve the management of childhood TE and help appropriate treatment to be initiated timely.

First, the cavity in the lungs was identified having an association with the presence of empyema. In fact, previously, it is thought that lung cavitation means a high TB burden, high infectivity, and is associated with TE (10). One possible explanation is that cavitation appears to first occur within the parenchymal consolidation and TE may result from an inadvertent rupture into the pleural space (11, 12). This situation is not uncommon (11). In addition, the association suggests an indirect evidence of the mechanism of pleural TB formation that TB strains in lungs disseminate into pleural space directly.

Second, in the study, surgical treatment was also associated with the presence of TE in children. This finding shows that in our study, most of childhood TE patients underwent surgical treatment. To treat the TE and minimize the morbidity and mortality, physicians were required to choose the appropriate procedure. However, the optimal treatment of childhood TE remains unclear (13). In addition, although most of children patients with empyema can be successfully treated with the conservative treatment, the conservative treatment has a disadvantage because of the long duration of hospital stay, especially in cases with advanced stages (4). Hence, surgical treatment, such as decortication, resection, and muscle flap closure, is still necessary in childhood pleural empyema (14). However, the choice of surgical approach may be determined by the stage of TE and the corresponding success rates may be influenced by the stage of the empyema, such as stage I and II (5, 6, 15, 16).

Third, pleural LDH, as a biomarker varied during the progression of pleural inflammation (17), is found to be associated with the presence of TE in children. It is thought that the initial level of pleural LDH reflects the serum level of LDH due to the filtration into the pleural space. In contrast, an increased LDH level is thought to have a cellular origin rather than a filtration origin (18). Similarly, pleural LDH can be used as a biomarker in the diagnosis of empyema. For example, Chen et al. found pleural LDH (≥1000 U/L) to be a maker discriminating complicated parapneumonic pleural effusion and empyema from uncomplicated parapneumonic pleural effusion with an AUC of 0.949 (19). Besides the above mentioned, pleural LDH also was found to be correlated with the duration of fever in patients with empyema, which may reflect the inflammation process (20, 21).

Low temperature was considered as another risk factor of the presence of TE among children with pleural TB. As known, the rise in the temperature due to empyema is a favorable symptom which may aid to shorten the delay in the treatment of TE. Therefore, the progression of developing TE was then stopped or delayed. Similarly, previous studies showed that absence of fever was significantly associated with total delay in patients with TB disease (9, 22–25). Interestingly, in the study, temperature was included in the final model. However, fever was not included in it. This may be explained by that fever, as an initiation symptom, was recalled by the patient before the admission to the hospital and the temperature was measured on the admission. Therefore, disease progression and previous treatment may made a significant impact and lead to the different analysis result. In contrast, a history of prolonged fever was confirmed as a significant clinical predictor for empyema in children (26, 27). Moreover, a longer duration of fever was associated with complicated community-acquired pneumonia, another serious complication as empyema (27). Based on these mentioned, further studies are required to investigate the association between temperature (or fever) and empyema, especially the corresponding biological plausible mechanism.

Although this study gives an insight into the management of childhood TE, the results of this study should be interpreted with some caution. First, retrospective collection of data and smaller number of cases are a significant concern for our study. Second, the study was based on a single center experience and our findings may generalize to other children populations. Furthermore, as the study had a relatively small sample size, a large study of childhood TE may be required to confirm these results.

Conclusions

Our findings suggest that early detection of the presence of TE in children remains a challenge in practice. Several characteristics, such as surgical treatment, lung cavitation, high pleural LDH level, and low temperature, have been identified as risk factors for the presence of TE in children with pleural TB. These findings may help to improve the diagnosis of TE and initiate appropriate treatment earlier. Moreover, it would also aid in shaping strategies for preventive management of childhood TE.

Funding

This work was supported by the Science Research and Technology Development Plan of Baise City (20203405).

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Statements

Data availability statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s.

Ethics statement

This study was conducted at the Shandong Provincial Chest Hospital and confronted for the Helsinki Declaration. The study protocol was approved by the Ethics Committee of Shandong Provincial Chest Hospital. Due to the retrospective nature of this investigation and the anonymous nature of the data collection, this retrospective study was exempt from the need for written informed consent by the Ethics Committee of Shandong Provincial Chest Hospital.

Author contributions

M-SW and J-LW: designed the study and supervised data collection. Y-HW: performed statistical analysis and drafted the initial manuscript. M-SW: collected data. All authors approved the final version of the report.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  • 1.

    WHO. Global Tuberculosis Report 2019. Geneva: World Health Organization (2019).

  • 2.

    LoutetMGSinclairCWhiteheadNCosgroveCLalorMKThomasHL. Delay from symptom onset to treatment start among tuberculosis patients in England, 2012–2015. Epidemiol Infect. (2018) 146:1511–8. 10.1017/S095026881800167X

  • 3.

    WenPWeiMHanCHeYWangMS. Risk factors for tuberculous empyema in pleural tuberculosis patients. Sci Rep. (2019) 9:19569. 10.1038/s41598-019-56140-4

  • 4.

    OzelSKKazezAKilicMKoseogullariAAYilmazEAygunAD. Conservative treatment of postpneumonic thoracic empyema in children. Surg Today. (2004) 34:1002–5. 10.1007/s00595-004-2859-5

  • 5.

    SinghAPShuklaAKSharmaPShuklaJ. Surgical management of stage III pediatric empyema thoracis. Lung India. (2018) 35:209–14. 10.4103/lungindia.lungindia_227_17

  • 6.

    MenonPRaoKLSinghMVenkateshMAKanojiaRPSamujhRet al. Surgical management and outcome analysis of stage III pediatric empyema thoracis. J Indian Assoc Pediatr Surg. (2010) 15:9–14. 10.4103/0971-9261.69134

  • 7.

    KumarAAsafBBLingarajuVCYendamuriSPulleMVSoodJ. Thoracoscopic decortication of stage III tuberculous empyema is effective and safe in selected cases. Ann Thorac Surg. (2017) 104:1688–94. 10.1016/j.athoracsur.2017.06.038

  • 8.

    BergerHAMorganrothML. Immediate drainage is not required for all patients with complicated parapneumonic effusions. Chest. (1990) 97:731–5. 10.1378/chest.97.3.731

  • 9.

    ZhangWHanCWangMSHeY. Characteristics and factors associated with treatment delay in pleural tuberculosis. QJM. (2018) 111:779–83. 10.1093/qjmed/hcy167

  • 10.

    McAdamsHPErasmusJWinterJA. Radiologic manifestations of pulmonary tuberculosis. Radiol Clin North Am. (1995) 33:655–78.

  • 11.

    MuderRRYuVLParryMF. The radiologic manifestations of Legionella pneumonia. Semin Respir Infect. (1987) 2:242–54.

  • 12.

    GargMPrabhakarNGulatiAAgarwalRDhooriaS. Spectrum of imaging findings in pulmonary infections. Part 1: Bacterial and viral. Pol J Radiol. (2019) 84:e205–13. 10.5114/pjr.2019.85812

  • 13.

    Balfour-LynnIMAbrahamsonECohenGHartleyJKingSParikhDet al. BTS guidelines for the management of pleural infection in children. Thorax. (2005) 60:i1–21. 10.1136/thx.2004.030676

  • 14.

    SoysalOTopcuSTastepeIKayaSCetinG. Childhood chronic pleural empyema: a continuing surgical challenge in developing countries. Thorac Cardiovasc Surg. (1998) 46:357–60. 10.1055/s-2007-1010253

  • 15.

    CobanogluUSayirFBiliciSMelekM. Comparison of the methods of fibrinolysis by tube thoracostomy and thoracoscopic decortication in children with stage II and III empyema: a prospective randomized study. Pediatr Rep. (2011) 3:e29. 10.4081/pr.2011.e29

  • 16.

    OyetunjiTADormanRMSvetanoffWJDepalaKJainSDekonenkoCet al. Declining frequency of thoracoscopic decortication for empyema—redefining failure after fibrinolysis. J Pediatr Surg. (2020) 55:2352–55. 10.1016/j.jpedsurg.2019.12.023

  • 17.

    UtineGEOzcelikUYalcinEDogruDKiperNAslanAet al. Childhood parapneumonic effusions: biochemical and inflammatory markers. Chest. (2005) 128:1436–41. 10.1378/chest.128.3.1436

  • 18.

    JosephJBadrinathPBasranGSahnS. Is the pleural fluid transudate or exudate? A revisit of the diagnostic criteria. Thorax. (2001) 56:867–70. 10.1136/thorax.56.11.867

  • 19.

    ChenSCChenWHsuWHYuYHShihCM. Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema. Lung. (2006) 184:141–5. 10.1007/s00408-005-2573-0

  • 20.

    PicardEJosephLGoldbergSMimouniFBDeebMKleidDet al. Predictive factors of morbidity in childhood parapneumonic effusion-associated pneumonia: a retrospective study. Pediatr Infect Dis J. (2010) 29:840–3. 10.1097/INF.0b013e3181dd1fc4

  • 21.

    ProesmansMGijsensBVan de WijdevenPDe CaluweHVerhaegenJLagrouKet al. Clinical outcome of parapneumonic empyema in children treated according to a standardized medical treatment. Eur J Pediatr. (2014) 173:1339–45. 10.1007/s00431-014-2319-1

  • 22.

    HeYHanCChangKFWangMSHuangTR. Total delay in treatment among tuberculous meningitis patients in China: a retrospective cohort study. BMC Infect Dis. (2017) 17:341. 10.1186/s12879-017-2447-0

  • 23.

    TamuraAHigakiNKusakaKAkashiSSuzukiJShimadaMet al. Doctor's delay in endobronchial tuberculosis. Kekkaku. (2013) 88:9–13.

  • 24.

    MeyssonnierVLiXShenXWangHLiDYLiuZMet al. Factors associated with delayed tuberculosis diagnosis in China. Eur J Public Health. (2013) 23:253–7. 10.1093/eurpub/cks037

  • 25.

    MalbasaMPesutD. Is there delay in diagnosis of pulmonary tuberculosis in an intermediate-to-low TB incidence setting. Pneumologia. (2011) 60:138–42.

  • 26.

    LahtiEPeltolaVVirkkiRAlanenMRuuskanenO. Development of parapneumonic empyema in children. Acta Paediatr. (2007) 96:1686–92. 10.1111/j.1651-2227.2007.00511.x

  • 27.

    KrenkeKKrawiecMKrajGPeradzynskaJKrauzeAKulusM. Risk factors for local complications in children with community-acquired pneumonia. Clin Respir J. (2018) 12:253–61. 10.1111/crj.12524

Summary

Keywords

tuberculous empyema, children, pleural tuberculosis, risk factor, tuberculosis

Citation

Wu Y-H, Wang J-L and Wang M-S (2021) Factors Associated With the Presence of Tuberculous Empyema in Children With Pleural Tuberculosis. Front. Pediatr. 9:751386. doi: 10.3389/fped.2021.751386

Received

01 August 2021

Accepted

27 September 2021

Published

29 October 2021

Volume

9 - 2021

Edited by

Renato Cutrera, Bambino Gesù Children Hospital (IRCCS), Italy

Reviewed by

Umberto Pelosi, Bambino Gesù Ospedale Pediatrico, Italy; Ilaria Corsini, Sant'Orsola-Malpighi Polyclinic, Italy

Updates

Copyright

*Correspondence: Jun-Li Wang Mao-Shui Wang

This article was submitted to Pediatric Pulmonology, a section of the journal Frontiers in Pediatrics

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics